BMS fined, former execs charged

Bristol-Myers Squibb agreed to pay a $300 million fine to defer prosecution on charges it manipulated sales and income figures, even as two former senior executives were charged with crimes related to the scandal. That brings its total fines to $800 million. The New York Times reported that the deal was in the works last week. Former CFO Frederick Schiff and executive vice president Richard Lane were charged with conspiracy and securities fraud.

- read this story from the AP for more

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.